As of 2026-11-13, the Relative Valuation of Crescita Therapeutics Inc (CTX.TO) is 0.02 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.79 CAD, the upside of Crescita Therapeutics Inc based on Relative Valuation is -97.1%.
The range of the Relative Valuation is (0.00) - 0.20 CAD.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 1.0x | 0.1x |
| Forward P/E multiples | 6.2x - 31.9x | 7.7x |
| Fair Price | (0.00) - 0.20 | 0.02 |
| Upside | -100.2% - -75.2% | -97.1% |
| Date | P/E |